Align Technology, Inc.

Align Technology, Inc.

ALGNNYSE / NASDAQHealthcareLarge cap

$155.17-$4.51 (-2.8%)

Last close · Data as of Nov 20, 2026

Market cap
$12.1B
P/E
29.4x
EV / EBITDA
13.5x
Revenue
$4.0B
Net margin
10.2%
ROCE
13.6%

+16.8% over the last year

Align Technology, Inc. price, 1Y

Daily closes.

Go deeper

Technical chart: candles, 28 indicators including moving averages, RSI and MACD, drawing tools and five colour themes

Open technical chart
Open technical chartCandles, 28 indicators, drawing tools

Performance

Price return, before dividends, to the 20 Nov 2026 close.

1M
+3.1%
3M
-2.4%
6M
-5.0%
1Y
+16.8%
5Y
-77.3%

52-week range

Day change -$4.51 (-2.8%) from $160 to $155 · Last close Nov 20, 2026

Best weekday to invest, historically

The same weekly amount in ALGN, bought on each weekday since 2021.

News & filings

What Align Technology filed, who traded, and what's next

How to read this

"News & filings" lists what the company itself has put on record with regulators, who inside it traded, the news that names it, and the next date we know of. Filings and releases are first-hand; news is third-party and may be thin for smaller companies. A day of insider filings is one row. Nothing here is a recommendation.

AI Summary

US Stock

StrengthThe company carries almost no debt: debt to equity of 0.03.

Concerns (1)

  • The P/E of 29.4 is 78% above the peer median of 16.5.

Prices to the 20 Nov 2026 close · Financial year: fiscal 2025

Rule-based from financial data. Not advice.

About the company

Align Technology, Inc. provides Invisalign clear aligners, Vivera retainers, and iTero intraoral scanners and services in the United States, Switzerland, and internationally.

Read moreShow less

Align Technology, Inc. provides Invisalign clear aligners, Vivera retainers, and iTero intraoral scanners and services in the United States, Switzerland, and internationally. The company's Clear Aligner segment offers Invisalign comprehensive package to treat adults and teens malocclusion and features, and orthodontic needs of teenage or younger patients; and Invisalign First Phase I and Invisalign First Comprehensive Phase 2 package for younger patients between the ages of six and ten years with a mixture of primary/baby and permanent teeth. This segment also provides Invisalign express, Invisalign lite, and Invisalign moderate; Invisalign Go, Invisalign Go express, and Invisalign Go Plus; retention products, Invisalign training, adjusting tools used by dental professionals during treatment, ancillary Invisalign accessory products, and other oral health products; Invisalign Professional Whitening system; Invisalign Palatal Expander, a 3D printed orthodontic device; and 3D printing solutions. Its Imaging Systems and CAD/CAM Services segment offers iTero intraoral scanning system, a single hardware platform for restorative or orthodontic procedures; exocad, a computer-aided design and computer-aided manufacturing software; orthodontist software for digital records storage, orthodontic diagnosis, and fabrication of printed models and retainers; and restorative software for general practitioner dentists, prosthodontists, periodontists, and oral surgeons. This segment also offers Invisalign outcome simulator, a chair-side and cloud-based application for the iTero scanner; Invisalign progress assessment tool; Align Oral Health Suite, a digital interface for dental consultations; iTero TimeLapse technology for doctors or practitioners to compare a patient's historic 3D scans to the present-day scan; and subscription software, disposables, rents scanners, and pay per scan services. Align Technology, Inc. was incorporated in 1997 and is headquartered in Tempe, Arizona.

Sector
Healthcare
Shares outstanding
72.5M

Valuation, profitability, growth and solvency at the latest close; hover a label for its meaning.

Valuation

Market cap
$12.1B
P/E
29.4x
P/B
3.0x
EV / EBITDA
13.5x
EV / Sales
2.7x
P/S
3.0x
52-week high
$197.51
52-week low
$132.81

Profitability

Operating margin
14.5%
Net margin
10.2%
EBITDA margin
20.4%
ROE
10.1%
ROCE
13.6%
ROA
6.6%
Asset turnover
0.65

Growth

Revenue
$4.0B
Revenue growth, 1Y
0.9%
Revenue CAGR, 3Y
2.6%
Net profit growth, 1Y
-2.6%
Free cash flow
$490.8M

Solvency

Current ratio
1.36
Debt / Equity
0.03
Debt / Assets
0.02
CFO / Net profit
1.45
Cash / Market cap
9.1%

Where the revenue went

Of every $100 of FY2025 revenue, $10 was left as net income.

Align Technology, Inc. income statement flow, FY2025
Align Technology, Inc. income statement flow, FY2025: flows
FromToAmount
RevenueCost of revenue$1.3B
RevenueGross profit$2.7B
Gross profitResearch and development$369.9M
Gross profitSelling, general and administrative$1.8B
Gross profitOther operating expenses$0.00
Gross profitOperating income$585.3M
Operating incomePretax income$585.3M
Operating incomeInterest and other expense$20.0k
Pretax incomeTax and other$174.9M
Pretax incomeNet income$410.4M

Revenue and net profit

Revenue grew 0.9% in FY2025; net profit is the dashed line.

Align Technology, Inc. revenue and net profit by fiscal year
Align Technology, Inc. revenue and net profit by fiscal year
DateRevenueNet profit
FY2022$3.7B$361.6M
FY2023$3.9B$445.1M
FY2024$4.0B$421.4M
FY2025$4.0B$410.4M

Cash flows

FY2025: $593.2M from operations, $490.8M free after investment (dashed).

Align Technology, Inc. operating and free cash flow by fiscal year
Align Technology, Inc. operating and free cash flow by fiscal year
DateOperating cash flowFree cash flow
FY2022$568.7M$276.8M
FY2023$785.8M$608.1M
FY2024$738.2M$622.7M
FY2025$593.2M$490.8M

Growth

Latest fiscal year 2025: each figure with its change over the year before.

Revenue
$4.0B+0.9%1Y
EBITDA
$822.7M+0.7%1Y
Net profit
$410.4M-2.6%1Y
Cash from operations
$593.2M-19.6%1Y
Free cash flow
$490.8M-21.2%1Y
Revenue CAGR, 3Y
2.6%
Net profit CAGR, 3Y
4.3%
YearRevenueEBITDANet profitFCFROERevenue growth 1YNet profit growth 1Y
FY2025$4.0B$822.7M$410.4M$490.8M10.1%+0.9%-2.6%

Monthly returns

Month-by-month returns of ALGN across the years, with the seasonal pattern.

Balance sheet

What the company owns and owes at the end of FY2025.

LineFY2025
Assets$6.2B
Liabilities$2.2B
Equity$4.0B
Paid-in capital$1.5B
Retained earnings$2.5B

Market cap against peers

8 peers: same sector, nearest by size.

Peers map

Healthcare companies placed by value, growth and quality; ALGN highlighted.

P/E against peers

ALGN trades at 29.4x earnings against a peer median of 16.5x (a 78% premium).

Not shown (no positive earnings and no EV / Sales): Viatris Inc.

Peer comparison

Same-sector peers by market cap, with the median.

CompanyMarket capP/EP/BROEEV/EBITDA
Align Technology, Inc.ALGNthis companyP/E ↑ premium$12.1B29.4x3.0x10.1%13.5x
Incyte CorporationINCY$20.2B15.7x3.9x24.9%9.8x
Viatris Inc.VTRS$18.5B—1.3x-23.9%—
Zimmer Biomet Holdings, Inc.ZBH$16.8B23.8x1.3x5.6%10.7x
Solventum CorporationSOLV$14.3B9.2x2.8x30.8%7.2x
DaVita Inc.DVA$12.3B16.5x-18.9x-114.7%9.3x
The Cooper Companies, Inc.COO$12.1B32.3x1.5x4.6%13.9x
Insulet CorporationPODD$10.1B41.0x6.7x16.3%21.2x
Universal Health Services, Inc.UHS$8.6B5.8x1.2x20.5%5.0x
Peer median—16.5x1.4x10.9%9.8x

Year-to-date ROI

ALGN since 1 January, against earlier years.

Historical volatility

ALGN's day-to-day swings over 30, 60 and 180 days.

Financial statements

Income statement, balance sheet and cash flow as reported, grouped into plain-language lines.

Consolidated figures in USD, fiscal years, newest first.

Operating margin by fiscal year

Align Technology, Inc. operating margin by fiscal year
Align Technology, Inc. operating margin by fiscal year
DateOperating margin
FY202217.5%
FY202317.0%
FY202416.8%
FY202514.5%
LineFY2025
Cost of revenueCost Of Revenue$1.3B
Gross profitGross Profit$2.7B
Operating expensesOperating Expense$2.1B
Research and developmentResearch And Development$369.9M
Selling, general and administrativeSelling General And Administration$1.8B
Total expensesTotal Expenses$3.4B
Pretax incomePretax Income$585.3M

Learn while you research

Academy chapters picked for Align Technology, Inc. and the metrics on this page.

  1. 01 Stock Valuation BasicsHow to think about what a fair price for a stock looks like.7 min read
  2. 02 Sector Analysis MattersHealthcare valuation is driven by pipelines and regulation, not just numbers.6 min read
  3. 03 Essential Stock RatiosP/E, P/B, EV/EBITDA, what they mean and when to use each.7 min read
  4. 04 How to Read a Cash-Flow StatementProfit can be manipulated; cash flow rarely lies.7 min read
Browse the full Equiscale Academy →